During the past decade, CH - Verdun conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH - Verdun" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials, followed by "Central Hospital, Nancy, France" with 1 trials sponsored, "Centre Hospitalier de Charleville-Mézières" with 1 trials sponsored, "Hospices Civils de Lyon" with 1 trials sponsored and "University Hospital, Brest" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH - Verdun" #1 collaborator was "Central Hospital, Nancy, France" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Institut Pasteur" with 1 trials as a collaborator and "Société Française d'Anesthésie et de Réanimation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "CH - Verdun" are "ALK Gene Mutation" (1 trials), "BRAF Gene Mutation" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "End Stage Renal Failure on Dialysis" (1 trials) and "Granulomatosis With Polyangitis" (1 trials). Many other conditions were trialed in "CH - Verdun" in a lesser frequency.

Most popular intervention types in "CH - Verdun" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Experimental Treatment (PCDE or PE + bevacizumab)" (1 trials), "Placebo" (1 trials), "Placebo 5mg/day extended of 12 additionnal months." (1 trials), "Prednisone 5mg/day extended of 12 additional months" (1 trials) and "Prerandomization Chemotherapy (PCDE or PE)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH - Verdun" are 7 trials for "All" genders.

Currently, there are NaN active trials in "CH - Verdun". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CH - Verdun, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH - Verdun, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".